Sun K X, Zheng R S, Zeng H M, Zhang S W, Zou X N, Gu X Y, Xia C F, Yang Z X, Li H, Chen W Q, He J
Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Cancer Research Institute, Cancer Hospital, Xinjiang Medical University, Urumqi 830011, China.
Zhonghua Zhong Liu Za Zhi. 2018 Nov 23;40(11):805-811. doi: 10.3760/cma.j.issn.0253-3766.2018.11.002.
To estimate lung cancer incidence and mortality in China using population-based cancer registry data in 2014 collected by National Central Cancer Registry of China (NCCRC). 449 cancer registries submitted cancer registry data in 2014. All datasets were evaluated and 339 registries' data which met the quality control criteria of NCCRC were analyzed. Numbers of new lung cancer cases and deaths were estimated using calculated incidence and mortality rates and corresponding national population stratified by areas, sexes and age groups. The standard population of Chinese census in 2000 and world Segi' s population were applied to calculate age-standardized incidence and mortality rates in China and worldwide, respectively. A total of 781, 500 new lung cancer cases were diagnosed in 2014. The crude incidence rate was 57.13 per 100 000 and the age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population (ASIRW) were 36.71 per 100 000 and 36.63 per 100 000, respectively. The cumulative incidence rate (0-74 years old) was 4.50%. Lung cancer was the most common cancer in male (ASIRW: 50.04 per 100 000) and the second most common cancer in female (ASIRW: 23.63 per 100 000). The incidence rates were slightly similar in urban areas and in rural areas (ASIRW: 36.64 per 100 000 vs 36.56 per 100 000). A total of 626 400 lung cancer deaths were reported. The crude mortality rate was 45.80 per 100 000 and the age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 28.49 per 100 000 and 28.31 per 100 000, respectively. The cumulative mortality rate (0-74 years old) was 3.32%. Lung cancer was the most common cause of cancer deaths both in male (ASMRW: 40.21 per 100 000) and female (ASMRW: 16.88 per 100 000). The mortality rate was slightly higher in rural areas than in urban areas (ASMRW: 28.63 per 100 000 vs 28.04 per 100 000). Both lung cancer incidence and mortality rates increased with age, and the peak age was 80-84 years group. The disease burden of lung cancer is heavy in China. Efficient national health policies and prevention and control strategies against lung cancer should be promoted.
利用中国国家癌症中心（NCCRC）收集的2014年基于人群的癌症登记数据，估算中国肺癌的发病率和死亡率。2014年有449个癌症登记处提交了癌症登记数据。对所有数据集进行了评估，并分析了339个符合NCCRC质量控制标准的登记处的数据。使用计算出的发病率和死亡率以及按地区、性别和年龄组分层的相应全国人口，估算新肺癌病例数和死亡数。分别应用2000年中国人口普查的标准人口和世界Segi人口，计算中国和全球的年龄标准化发病率和死亡率。2014年共诊断出781,500例新肺癌病例。粗发病率为每10万人57.13例，按中国标准人口计算的年龄标准化发病率（ASIRC）和按世界标准人口计算的年龄标准化发病率（ASIRW）分别为每10万人36.71例和36.63例。累积发病率（0 - 74岁）为4.50%。肺癌是男性中最常见的癌症（ASIRW：每10万人50.04例），是女性中第二常见的癌症（ASIRW：每10万人23.63例）。城市地区和农村地区的发病率略有相似（ASIRW：每10万人36.64例对36.56例）。共报告了626,400例肺癌死亡。粗死亡率为每10万人45.80例，按中国标准人口计算的年龄标准化死亡率（ASMRC）和按世界标准人口计算的年龄标准化死亡率（ASMRW）分别为每10万人28.49例和28.31例。累积死亡率（0 - 74岁）为3.32%。肺癌是男性（ASMRW：每10万人40.21例）和女性（ASMRW：每10万人16.88例）中癌症死亡的最常见原因。农村地区的死亡率略高于城市地区（ASMRW：每10万人28.63例对28.04例）。肺癌的发病率和死亡率均随年龄增长而上升，高峰年龄为80 - 84岁年龄组。中国肺癌的疾病负担沉重。应推行有效的国家卫生政策以及肺癌防控策略。
Zhonghua Zhong Liu Za Zhi. 2018-11-23
Zhonghua Zhong Liu Za Zhi. 2019-1-23
Zhonghua Zhong Liu Za Zhi. 2018-8-23
Zhonghua Liu Xing Bing Xue Za Zhi. 2015-8
Zhonghua Zhong Liu Za Zhi. 2023-3-23
Zhonghua Zhong Liu Za Zhi. 2018-9-23
Chin J Cancer Res. 2016-2
Zhonghua Zhong Liu Za Zhi. 2017-10-23
Zhonghua Zhong Liu Za Zhi. 2018-1-23
Medicine (Baltimore). 2017-6
Nan Fang Yi Ke Da Xue Xue Bao. 2020-12-30
Medicine (Baltimore). 2020-12-11
Zotero 插件